Literature DB >> 2403414

Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.

H Kalofonos1, G Rowlinson, A A Epenetos.   

Abstract

Indium-111-labeled AUA1 tumor-associated monoclonal antibody raised against an antigen of colon adenocarcinoma was used to evaluate the effect of ionizing radiation on antibody uptake by the LoVo adenocarcinoma cell line grown as a xenograft in nude mice. Tumors were exposed to single doses of external X-irradiation of between 400 and 1600 cGy followed, 24 h later, by administration of specific or nonspecific antibody. Animals were sacrificed 3 days after antibody administration. At doses higher than 400 cGy, tumor uptake with both specific and nonspecific antibody was significantly increased. No difference in changes in tumor volume was observed between the groups receiving irradiation and the controls. Specific antibody uptake by tumors was always significantly higher than nonspecific having an approximate 4-fold binding advantage. Vascular permeability and the vascular volume of irradiated and control tumors was measured 24 and 72 h after irradiation, using iodine-125-labeled nonspecific antibody and labelling of the red blood cells in vivo with 99mTcO4. At doses higher than 400 cGy, vascular permeability in the tumor 24 h after irradiation was significantly increased (P less than 0.05), while the vascular volume decreased (P less than 0.001) compared to control values. However at 72 h after irradiation there was no difference between treated and control groups. The results obtained in this study suggest a potential value of external irradiation to increase monoclonal antibody uptake by tumors governed mainly by the increased vascular permeability of the tumor vasculature soon after the irradiation exposure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403414

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1990-10       Impact factor: 4.033

Review 2.  Improving external beam radiotherapy by combination with internal irradiation.

Authors:  A Dietrich; L Koi; K Zöphel; W Sihver; J Kotzerke; M Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-03-18       Impact factor: 3.039

Review 3.  Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.

Authors:  S E Strand; M Ljungberg; J Tennvall; K Norrgren; M Garkavij
Journal:  Med Biol Eng Comput       Date:  1994-09       Impact factor: 2.602

4.  Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts.

Authors:  K Nakamura; A Kubo
Journal:  Eur J Nucl Med       Date:  1994-09

5.  [Radioimmunoscintimetry for intraoperative lymph node diagnosis in colorectal cancer].

Authors:  J Fass; R Bares; R Reinartz; J Braun; B Hauptmann; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1993

6.  A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption.

Authors:  C Hartmann; D C Bloedow; D G Dienhart; R Kasliwal; T K Johnson; R Gonzalez; P A Bunn
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

Review 7.  Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Authors:  Sergey V Kozin; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2012-05-09       Impact factor: 13.506

8.  Influence of tumour size on uptake of(111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft model.

Authors:  K J Harrington; G Rowlinson-Busza; K N Syrigos; R M Abra; P S Uster; A M Peters; J S Stewart
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

Review 9.  Radionuclide carriers for targeting of cancer.

Authors:  Stavroula Sofou
Journal:  Int J Nanomedicine       Date:  2008

10.  Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.

Authors:  C J Li; Y Miyamoto; Y Kojima; H Maeda
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.